Skip to main content
. 2016 Mar 20;129(6):723–730. doi: 10.4103/0366-6999.178016

Figure 2.

Figure 2

Methodological quality of the included studies assessing Aidi injection combined with NP chemotherapy for the treatment of nonsmall cell lung cancer. (a) Bias risk in clinical studies; (b) Summary of bias risk in clinical studies.